About 300 reports

  • Autoimmune diseases
  • Localized autoimmune disease diagnostics
  • Autoimmune Disease
  • World
  • Abbott Laboratories, Inc.
  • EUROIMMUN AG
  • Roche Group

autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE ## North America systemic autoimmune disease diagnostics market, by type, 2013 - 2025 (USD Million) TABLE ## North America localized autoimmune disease diagnostics mark

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • World
  • Market Size

The global Autoimmune Disease Diagnostics Market by Type 2017 - 2023 ##. ## localized autoimmune disease diagnostics ##. ## systemic autoimmune disease diagnostics ##.

  • Autoimmune Disease
  • Asia
  • Europe
  • North America
  • Market Size

Autoimmune Disease Diagnostics: Market Snapshot ##. ##.

  • Autoimmune Disease
  • Diagnostics
  • Pathology
  • World
  • Market Size
  • AUTOIMMUNE DISEASES 2015-2020
  • RISING PREVALENCE OF AUTOIMMUNE DISEASES
  • Autoimmune Disease
  • World
  • Biogen Idec Inc.
  • Pfizer Inc.
  • Remicade group

Hoffmann-La Roche AG ##. ## Biogen Idec Inc ##. ## Teva Pharmaceuticals Industries Limited ##. ## UCB S. A. ##. ## Sanofi-Aventis SA ##. ## Novartis AG ##. ## Shire Plc List of Tables ## Global Autoimmune Disease Therapeutics Market Outlook, By Region (2013-2022) ($MN) ## Global

  • Autoimmune Disease
  • Pathology
  • World
  • Forecast

Lab Test IVD for Autoimmune Disease Diagnostics Market: Application Movement Analysis ##. ## U. S.

  • Autoimmune Disease
  • Diagnostics
  • Laboratory
  • United States
  • Forecast

Analysis of the US Autoimmune Disease Diagnostics Market ## ANALYSIS OF THE US AUTOIMMUNE DISEASE DIAGNOSTICS MARKET Executive Summary ## Scope and Segmentation ## Key Predictions: US Autoimmune Disease Diagnostics Market ## Current Trends in the

  • Autoimmune Disease
  • Pathology
  • United States
  • Forecast
  • Market Size
  • MARKET SEGMENTATION OF GLOBAL AUTOIMMUNE DISEASE MARKET BY DRUG CLASS
  • Assessment
  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.

Autoimmune Diseases Market in the US 2015-2019 ##.

  • Autoimmune Disease
  • Pathology
  • Market Size
  • Increased prevalence of autoimmune diseases
  • Limitations of autoimmune disease diagnostics
  • Autoimmune Disease
  • Forecast
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Thermo Fisher Scientific, Inc.

Autoimmune Disease Diagnostics: Global Markets TABLE OF CONTENTS CHAPTER ## INTRODUCTION ## STUDY GOALS AND OBJECTIVES ## SCOPE OF REPORT ## INTENDED AUDIENCE ## INFORMATION SOURCES ## ANALYST CREDENTIALS ## RELATED BCC RESEARCH REPORTS ## BCC RESEARCH WEBSITE ## DISCLAIMER ## CHAPTER ## EXEC

  • Autoimmune Disease
  • Pathology
  • Market Size
  • 8.5.2 HOSPIRA'S INFLECTRA VERSUS J&J'S REMICADE IN KEY AUTOIMMUNE DISEASES
  • PRESENTS AN ASSESSMENT OF ELI LILLY'S PSORIASIS PORTFOLIO.
  • Autoimmune Disease
  • World
  • Amgen Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • AUTOIMMUNE DISEASES
  • Market definition
  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • SEGMENTATION OF GLOBAL MUSCULOSKELETAL DISORDER THERAPEUTICS MARKET BY REVENUE 2015
  • BASED ON THE TYPE OF DISEASE, THE GLOBAL MUSCULOSKELETAL DISORDER THERAPEUTICS MARKET CAN BE SEGMENTED AS FOLLOWS:
  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly & Co.
  • GROWING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES
  • HIGH COSTS OF BIOLOGICALS
  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Minimal Investigative Measures Required Before Prescribing Biologics for Psoriasis
  • Autoimmune Disease
  • Amgen Inc.
  • Can-Fite BioPharma Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Minimal Investigative Measures Required Before Prescribing Biologics for Psoriasis
  • Autoimmune Disease
  • Amgen Inc.
  • Can-Fite BioPharma Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Minimal Investigative Measures Required Before Prescribing Biologics for Psoriasis
  • Autoimmune Disease
  • Amgen Inc.
  • Can-Fite BioPharma Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.5.2 Hospira's Inflectra Versus J&J's Remicade in Key Autoimmune Diseases
  • Minimal Investigative Measures Required Before Prescribing Biologics for Psoriasis
  • Autoimmune Disease
  • Amgen Inc.
  • Can-Fite BioPharma Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GLOBAL SCLERODERMA TREATMENT MARKET BY OTHERS DRUG CLASS 2016-2021 ($ MILLIONS)
  • INTRODUCTION OF STEM CELLS IN SCLERODERMA TREATMENT

Autoimmune diseases such as scleroderma are chronic, and they affect multiple organs.

  • Autoimmune Disease
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • 7.2.3 CELLTRION INC. - MAJOR BIOSIMILARS APPROVED FOR MARKETING
  • 5.4 CHRONIC AND AUTOIMMUNE DISORDERS BIOSIMILARS MARKET AND FORECAST

The biosimilars for chronic and autoimmune diseases are showing impressive growth and expecting a salutary growth during the analysis period.

  • Autoimmune Disease
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • GROWING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES
  • HIGH COSTS OF BIOLOGICALS
  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.

The diagnosed prevalent cases are further segmented by severity (mild to moderate, moderate to severe, and severe to fulminant) and by comorbid autoimmune diseases (psoriasis, ankylosing spondylitis, and pyodermagangrenosum).

  • Autoimmune Disease
  • Germany
  • Italy
  • Spain
  • Forecast
  • US: AUTOIMMUNE DISEASE PREVALENCE, 2016
  • AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION
  • Autoimmune Disease
  • Pathology
  • World
  • Forecast
  • Thermo Fisher Scientific, Inc.
  • AUTOIMMUNE DISEASES
  • TNF INHIBITORS
  • Autoimmune Disease
  • World
  • Market Size
  • AbbVie Inc.
  • Amgen Inc.
  • 2.1.2 SYSTEMIC LUPUS ERYTHEMATOSUS
  • 2.3 Etiology and Pathophysiology

The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis.

  • Autoimmune Disease
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • Autoimmune and inflammatory diseases
  • RHEUMATOID ARTHRITIS
  • Arthritis
  • Autoimmune Disease
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Abstract Psoriasis (PsO) is a chronic autoimmune disease that results from the overproduction of skin cells that causes redness and inflammation.

  • Anti Rheumatic
  • Autoimmune Disease
  • Therapy
  • United States
  • World
  • INCREASE IN PUBLIC AWARENESS PROGRAMS
  • Global Vasculitis Treatment Market is Expected to Grow to $517.64 mn by 2021
  • Autoimmune Disease
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc